Abstract
The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.
| Original language | English |
|---|---|
| Title of host publication | Medicine Price Surveys, Analyses and Comparisons |
| Subtitle of host publication | Evidence and Methodology Guidance |
| Editors | Sabine Vogler |
| Publisher | Elsevier |
| Chapter | 2.3 |
| Pages | 45-60 |
| Number of pages | 16 |
| Edition | 1st |
| ISBN (Electronic) | 9780128132128 |
| ISBN (Print) | 9780128131664 |
| DOIs | |
| Publication status | Published - 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Medicine Prices in Asia–Pacific Countries'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver